Achieve life sciences announces results from evaluation of cytisinicline (cytisine) versus chantix® (varenicline) in 5-ht3 receptor binding assay study

Seattle, and vancouver, british columbia, sept. 18, 2020 /prnewswire/ -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced data presented at...

ACHV Ratings Summary

ACHV Quant Ranking